Sleuths gain in helping damaged nerves. (amyotrophic lateral sclerosis): An article from: The Masthead

This digital document is an article from The Masthead, published by National Conference of Editorial Writers on June 22, 1993. The length of the article is 793 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

From the supplier: Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, attacks the neurons in the brain and spinal cord, which may eventually lead to the malfunctioning of the muscles. Its cause is still unknown. ALS researchers plan to test a drug called ciliary neutrotrophic factor on several ALS patients. The test is being sponsored by the New York-based Regeneron Pharmaceuticals Inc. Although the test is not yet approved by the US Food and Drug Administration, the fact that a major drug company has invested on the search for the cure of ALS, is encouraging enough for ALS patients.

Citation Details
Title: Sleuths gain in helping damaged nerves. (amyotrophic lateral sclerosis)
Author: Brian Dickinson
Publication:The Masthead (Magazine/Journal)
Date: June 22, 1993
Publisher: National Conference of Editorial Writers
Volume: v45 Issue: n2 Page: p21(1)

Distributed by Thomson Gale